Keymed Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	12,815	8,516	13,586	14,267	9,651	-	Upgrade
Market Cap Growth	-37.32%	-37.32%	-4.77%	47.83%	-	-	Upgrade
Enterprise Value	11,324	6,555	10,725	10,424	15,170	-	Upgrade
Last Close Price	46.50	30.90	49.10	51.00	34.50	-	Upgrade
PS Ratio	28.13	18.69	34.83	126.12	71.30	-	Upgrade
PB Ratio	4.87	3.23	4.13	3.78	2.16	-	Upgrade
P/TBV Ratio	4.89	3.25	4.13	3.78	2.15	-	Upgrade
EV/Sales Ratio	24.85	14.39	27.49	92.15	112.08	-	Upgrade
Debt / Equity Ratio	0.30	0.30	0.14	0.04	0.01	-1.33	Upgrade
Asset Turnover	0.11	0.11	0.09	0.03	0.05	-	Upgrade
Inventory Turnover	0.13	0.13	0.66	0.07	1.02	-	Upgrade
Quick Ratio	3.04	3.04	8.80	8.45	31.55	4.42	Upgrade
Current Ratio	3.30	3.30	9.36	8.72	31.96	4.75	Upgrade
Return on Equity (ROE)	-18.85%	-18.85%	-11.31%	-8.69%	-305.24%	-	Upgrade
Return on Assets (ROA)	-10.23%	-10.23%	-7.32%	-8.65%	-10.09%	-15.67%	Upgrade
Return on Capital (ROIC)	-11.80%	-11.80%	-8.33%	-9.52%	-11.15%	-20.89%	Upgrade
Earnings Yield	-4.28%	-6.44%	-2.91%	-2.44%	-49.44%	-	Upgrade
FCF Yield	-8.28%	-12.46%	-5.53%	-5.39%	-4.92%	-	Upgrade
Buyback Yield / Dilution	-0.22%	-0.22%	-0.09%	-62.34%	-139.72%	-	Upgrade

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.